Brind.

Maura Healey criticized Trump administration funding while facing a Republican primary challenger, who is the CEO of AbioMed.

1 report, 1 independent Updated Aug 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Maura Healey criticized Trump administration funding while facing a Republican primary challenger, who is the CEO of AbioMed.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Former CEO of AbioMed, Geoff Diehl, is identified as a staunch critic of Donald Trump and a political figure.Sub-event
  2. Healey criticizes Trump funding amid primary race where AbioMed CEO is a challenger.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped